Introduction
Hypertension is one of the leading causes of global burden of disease. 7.6 million Deaths (13-15% of the total) and 92 million disability adjusted life worldwide were attributable to high blood pressure in 2001. 1 Hypertension prevalence is 33.5% in non-Hispanic blacks, 28 .9% in whites seen in America. In India the prevalence rate is 59.9 and 69.9 per thousand males and females respectively in the urban and 35.5 and 35.9 per thousand males and females respectively in rural population. The likelihood of hypertension increases with age and among individuals age>60 the prevalence is 65.4%. 2 There is no natural dividing line between high and normal blood pressure as it is a continuous variable. There have been multiple proposed cut off points for the definition of high blood pressure. According to the JNC-VII criteria (Joint National Committee), systolic pressure equal or more than 140 mm Hg and or a diastolic pressure equal to or greater than 90 mmHg is taken as the diagnostic criteria of hypertension. 2 The classification is given in table1.
Numerous studies have implied the association of hypertension with vascular oxidative stress. Potentially harmful reactive oxygen species (ROS) are constantly produced during normal aerobic metabolism and they are safely removed by a variety of biological antioxidants. They are involved in maintaining cellular and physiological equilibrium such as regulation of vascular tone, sensing oxygen tension and endothelial dysfunction, but it is unknown whether this abnormality is a primary event or a consequence of increased blood pressure. 3 Antioxidant protection can operate at several different levels within cells by preventing radical formation, repairing oxidative damage caused by radicals, increasing the elimination of damaged molecules and apoptosis of excessively damaged tissue. When prooxidants increase or antioxidants fail, a situation of oxidative stress arises . (3, 4) It is mentioned that oxidative stress inactivates endothelium derived nitric oxide, the most important endogenous vasodilator which promotes vasoconstriction. Due to damage of vascular smooth muscle cells and endothelial cells there is increased endothelial permeability and stimulation of inflammation. These changes may lead to altered endothelial cell eicosanoid metabolism, increases the intra cellular free calcium concentration. Oxidative stress promotes vascular smooth muscle cell proliferation, hypertrophy and collagen deposition so that there is narrowing of vascular lumen. Increased oxidative stress also impairs endothelial relaxation and increases vascular contractility.ROS induced vasoconstriction include oxidation of arachidonic acid and formation of vasoconstrictive eicosanoids (prostaglandin F 2α ) it also inhibits the synthesis of vasodilator PGI. 7 ROS can activate signaling cascades in vascular smooth muscle cells that induce remodeling in resistance arteries, resulting in increasing wall rigidity and narrowing of the lumen. This changes have been assumed to cause and progression of blood pressure. Some studies have reported that antioxidant therapy have improved vascular function and reduced blood pressure in experimental animal models and humans. Nevertheless, the available data is inconclusive and the relationship between blood pressure and oxidative stress in humans needs to be elucidated. 8, 9 Hence, this study was designed to (a) compare oxidative stress in hypertensive and normotensive subjects; (b) to find a correlation between low antioxidant status with the severity of hypertension.
II. Material and methods
This case-control study included 96 hypertensive patients (male-60, female-36) attending medicine outpatient department of M.K.C.G. Medical College and Hospital. An equal number of age and sex matched healthy controls were included. The study was approved institutional ethics committee.
The hypertensive patients fulfilling the following criteria like newly diagnosed, age 50-65 years, without any associated systemic diseases such as diabetes mellitus, cardiovascular, renal and hepatic diseases were included in this study. None of the hypertensive patients had history of smoking or alcohol. The physiological parameters such as age, height, weight, blood pressure and duration of disease at the time of admission were noted.
Measurement of blood pressure (15) Each subject was seated in a quiet and comfortable position for five minutes, with feet on the floor and arm supported at heart level and then two readings of BP were measured on the right arm, five minutes apart with a mercury sphygmomanometer (cuff size 12.5 X 40 cm) with auscultator method of BP measurement. BP readings were confirmed in the contra lateral arm at the same time. The SBP and DBP were read to the nearest 2mm Hg. First and fifth phases of Korotkoff's sounds were taken as criteria for SBP and DBP respectively. The average of the two consecutive readings was recorded.
All the biochemical parameters were estimated in the Regional diagnostic centre of the department of Biochemistry, M.K.C.G Medical College and hospital. Fasting venous blood was collected and was immediately assayed. Blood sugar, total cholesterol, Triglyceride (TG), HDLcho ( high density lipoprotein cholesterol), LDLcho (low density lipoprotein cholesterol) were estimated using commercial kits adapted to EM360 Erba Transasia auto analyser. All the kits were purchased from Erba diagnostics, Mannheim, Germany.
Oxidative stress was measured by oxidation products in xylenol orange version 2 (FOX2 assay) 10 . The FOX2 reagent comprises two stock solutions, A and B. stock solution A was prepared by dissolving ammonium ferrous sulphate in sulphuric acid. Subsequently Xylenol orange was added to the above solution. Solution B was prepared by dissolving BHT (Butylated Hydroxy Toluene) in methanol. Total oxidant stress was measured as equivalent of H 2 O 2 in μmol/L. Antioxidant power of serum was measured by Ferric Reducing Ability of Plasma capacity (FRAP assay). For FRAP assay reagents includes acetate buffer, TPTZ (2,4,6-tripyridyl-striazine). 11 Total antioxidant power was expressed as equivalent of Ferrous sulphate in μmol/L. Statistical Analysis Data is expressed as mean ± standard deviation (SD). The data was analysed by students t test for unpaired data. Correlation was derived by Pearson's correlation analysis. A p value < 0.05 was considered significant. Statistical analysis was done using SPSS version 16 software. Table I shows the classification of hypertension,which is classified into prehypertension and hypertension. Demographic profile of the study subjects is depicted in Table 2 it included 60 males and 36 females with the male-to-female ratio of 1.66 and controls consisted of 55 male and 41 females with a male-tofemale ratio of 1.42 Cases had a mean age of 58±8.2 years compared to the mean age 58±8.6 years of controls . Duration of hypertension was 4.5±1.2 years. SBP of hypertensive cases 164.5±13.6mm Hg and DBP 99.06± 11.9 as compared to controls with SBP 118.7±4.87mm Hg and DBP 82.34±3.5mm Hg. There was no significant difference between the BMI of cases (24.3±4.2) and that of controls (24.06±3.7).
III. Results
Clinical and laboratory data as represented in Table 3 . Significant difference was not observed between the blood glucose of cases (107±6.4 mg/dl) and that of controls (101±8.6). There was significant (p value 0.001) difference in the lipid profile between cases (total cholesterol-201.14±6.12 mg/dl; triglyceride-159.18±11.7 mg/dl; HDL cholesterol-31.08±3.59 mg/dl; LDL cholesterol-182.03±14.86 mg/dl) and controls (total cholesterol-147.41±1.74mg/dl; triglyceride-89.40±22.2mg/dl; HDL cholesterol-36.07±6.91 mg/dl; LDLcholesterol-132.03±18.07 mg/dl). Figure 1 shows the relationship between oxidant load (FOX2) and total antioxidant capacity (FRAP). When the FOX2 label increases the FRAP level falls. Table 4 and Figure 2 shows there is a significant increase in the oxidant load and a significant decrease in the total antioxidant power of the serum of hypertensive patients as compared to the normotensive controls. The serum oxidant load measured by FOX2 assay of cases is 12.4±1.6µmol/L (equivalent of H 2 O 2 ) and that of controls is 4.33±1.7µmol/L (equivalent of H 2 O 2 ) with p value 0.001. The serum total antioxidant level was observed to decrease with an increasing severity of hypertension. The total serum antioxidant (FRAP) of the cases is 61.37±4.71µmol/L(equivalent of Ferrous Sulphate) and that of the controls is 423±15.23µmol/L(equivalent of Ferrous Sulphate). Pearson's correlation revealed a significant negative correlation between oxidant load and antioxidant status with R 2 =-0.797 and p value=0.000. Table 5 depict the correlation between the oxidative stress parameters and age, BMI, SBP, DBP and lipid profile. Significant positive correlation was observed between lipid profile, increased systolic and diastolic blood pressure and oxidant load (FOX2). Significant negative correlation was observed between lipid profiles, increased systolic and diastolic blood pressure and antioxidant capacity (FRAP).
IV. Discussion
Hypertension is a complex multifactorial disease. hypertension is characterized by an increase in systolic and/or diastolic blood pressure (SBP and DBP) than the upper limit of the optimal level as per the JNC VII guidelines. In the present study, both the SBP and DBP of all the cases were significantly higher than that of controls. 12 Confounding factors which might influence the study parameters were minimized since all the participants were drawn from the same population. Almost all the study participants had similar diet, lifestyle and daily exercise habit patterns.
The findings of the present study demonstrate a strong association between blood pressure and oxidative stress parameters. The increased oxidative stress parameter levels observed in the hypertensive cases of our study is consistent with the findings of several previous studies (13) (14) (15) . However, our study findings are not in agreement with certain other studies, where no significant association was found. (16) (17) (18) . Russo et al showed that essential hypertension is associated with greater lipoperoxidation than normal and an imbalance in antioxidant status suggesting oxidative stress is important in the pathogenesis of essential hypertension. 19 The correlation of blood pressure with oxidative stress parameters in hypertensive subjects suggests that these parameters have a blood pressure modulating effect (20) (21) . In our study hypertensive cases showed an impaired total antioxidant status, which is in agreement with the previous studies (22) (23) (24) . Further, the negative correlation between SBP and DBP with total antioxidant status assed by FRAP levels suggests the importance of serum antioxidant status in blood pressure modulation. In normotensives subjects there was no significant positive correlation between blood pressure and antioxidant status. Many recent studies have documented that exposure to ROS increase the expression of antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase (25, 26) . Thus, genes encoding these enzymes are co-ordinately regulated by antioxidant responsive elements (ARE) in their regulatory regions, a process which occurs through the activation of transcription factor NF-E2-related factor 2 (Nrf2) (27) . The binding of Nrf2 to AREregions in genes causes up-regulation of the downstream genes which regulate the antioxidant activity of enzymes in response to ROS activity. It may be noted that this mechanism is triggered in most patients of hypertension. in response to their increased oxidant load as compared to normotensives. The significant negative correlation between SBP vs FRAP and DBP vs FRAP in hypertensive cases in our study strongly indicates the low antioxidant status of the patients. A significant positive correlation between SBP and DBP vs FOX2 value shows the increased oxidative stress in patients of hypertension. Table 3 shows a significant difference in lipid parameters of the hypertensive cases as compared to controls. Triglycerides, Total cholesterol, LDL cholesterol are high and HDL cholesterol is low in hypertensive cases as compared to controls. Dyslipidaemia causes a prolonged increase in lipid per oxidation. This is due to generation of reactive oxygen species by leukocytes and p47 phox protein along with the activation of nuclear factor KB and inflammation. 28 Further more we measured the FRAP and FOX2 level in different stages of hypertension. Table 4 shows the FRAP level declines as the severity of hypertension increases, there is a significant difference (p<0.001) found between prehypertension and stage II hypertension. Similarly the FOX2 level increases accordingly with increasing severity (p<o.001). In table 2 & 4 we found that there is no significant difference between age, BMI and oxidative stress parameters. Irrespective of age and BMI dyslipidaemia has a strong relationship with FRAP and FOX2 assay.
The high oxidative stress in hypertensive patients may be due to their decreased antioxidant activity and/or an increased oxidant load. This derangement leads to damage to various biomolecules in hypertensive patients 29 . As a consequence, increased oxidant load leads to reduction in endothelium-dependant vasodilatation of vascular smooth muscles in hypertensive patients (30) (31) (32) . This increase in blood pressure contributes to an increase in ROS and oxidant load, thereby enhancing the ROS mediated hypertension through a complex interdependent cycle.
V. Conclusion
From our study it is clear that increase in oxidative stress is associated with hypertension. It is not clear whether the reactive oxygen species initiate the development of hypertension or are due to the vascular damage observed in hypertension. From the above data in our study it is concluded that oxidative stress increases according to the severity of hypertension. As it is not clearly established whether the oxidative stress is the cause or the effect of the hypertension, the potential value of antioxidant supplements in diet to reduce blood pressure via the reductions in oxidative stress should be further evaluated. Data is represented as mean ± SD. Statistical significance is derived by unpaired student's t test. A p value of < 0.05 was considered significant. Significant positive correlation was observed between lipid profile, increased systolic and diastolic blood pressure and oxidant load (FOX2). Significant negative correlation was observed between lipid profiles, increased systolic and diastolic blood pressure and antioxidant capacity (FRAP). Figure 1 shows the correlation of the total antioxidant defense load(FRAP) and oxidative stress level(FOX2).
It shows when the FOX2 level increases FRAP value decreases accordingly.
Figure2 showing correlation of FRAP and FOX2 with blood pressure Series 1 depicts FOX2 levels and Series 2 shows FRAP levels. Significant positive correlation was observed between increased blood pressure and FOX2 levels (total oxidant load) and significant negative correlation was found between blood pressure and FRAP levels (total antioxidant status).
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